Literature DB >> 6215926

Functional aberration of T cell subsets in patients with Behçet's disease.

T Sakane, H Kotani, S Takada, T Tsunematsu.   

Abstract

Abnormalities of concanavalin A-induced suppressor activity and autologous mixed lymphocyte reaction (which is part of the regulatory role of T cells on lymphocyte functions) were observed in patients with preactive Behçet's disease. However, both the functions returned to normal when the patients entered an active or inactive phase of disease. Thus, a diminution of suppressor function appears to be necessary for the initiation or potentiation of autoimmune and/or inflammatory abnormalities in Behçet's disease. Results of studies of T cell subsets and their functional analysis in patients with preactive Behçet's disease provide further evidence in support of this hypothesis.

Entities:  

Mesh:

Year:  1982        PMID: 6215926     DOI: 10.1002/art.1780251110

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  A defect in immunoregulatory synovial fluid T cells in Behçet's syndrome.

Authors:  J Alcocer-Varela; A Laffon; C Abud-Mendoza; D Alarcon-Segovia
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

2.  Thalidomide and cell mediated immunity in Behçet's disease.

Authors:  M Hamza; K Hamzaoui; K Ayed; M Eleuch; A Zribi
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

3.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

4.  Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.

Authors:  G Valesini; P Pivetti-Pezzi; F Mastrandrea; A Moncada; M Cuomo; P G Natali
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

5.  Neuro-Behçet: clinical features and MRI correlates.

Authors:  F Federico; M G Damiani; R De Blasi; M De Mari; P Lamberti; P Lattanzi; A Carella
Journal:  Ital J Neurol Sci       Date:  1993-01

Review 6.  Cytotoxic T-cell lymphoma arising in Behçet disease.

Authors:  Yukitaka Katsura; Kazumi Suzukawa; Hiroshi Kojima; Chikashi Yoshida; Seiichi Shimizu; Harumi Mukai; Yuichi Hasegawa; Shigehiko Imagawa; Naoyoshi Mori; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

7.  Treatment of Behçet's disease with thalidomide.

Authors:  M H Hamza
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

8.  Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.

Authors:  M Schlesinger; D Ilfeld; Z T Handzel; Y Altman; O Kuperman; S Levin; C Bibi; L Netzer; N Trainin
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease.

Authors:  Gamze Alayli; Fatma Aydin; Ahmet Yilmaz Coban; Yüksel Süllü; Ferhan Cantürk; Yüksel Bek; Belma Durupinar; Tayyar Cantürk
Journal:  Clin Rheumatol       Date:  2007-01-09       Impact factor: 3.650

10.  Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

Authors:  Antonina Accardo-Palumbo; Anna Rita Giardina; Francesco Ciccia; Angelo Ferrante; Alfonso Principato; Rosalia Impastato; Ennio Giardina; Giovanni Triolo
Journal:  Arthritis Res Ther       Date:  2010-06-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.